X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
46
PharmaCompass offers a list of Voxilaprevir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Voxilaprevir manufacturer or Voxilaprevir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Voxilaprevir manufacturer or Voxilaprevir supplier.
PharmaCompass also assists you with knowing the Voxilaprevir API Price utilized in the formulation of products. Voxilaprevir API Price is not always fixed or binding as the Voxilaprevir Price is obtained through a variety of data sources. The Voxilaprevir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 0570F37359 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 0570F37359, including repackagers and relabelers. The FDA regulates 0570F37359 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 0570F37359 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 0570F37359 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 0570F37359 supplier is an individual or a company that provides 0570F37359 active pharmaceutical ingredient (API) or 0570F37359 finished formulations upon request. The 0570F37359 suppliers may include 0570F37359 API manufacturers, exporters, distributors and traders.
click here to find a list of 0570F37359 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 0570F37359 Drug Master File in Korea (0570F37359 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 0570F37359. The MFDS reviews the 0570F37359 KDMF as part of the drug registration process and uses the information provided in the 0570F37359 KDMF to evaluate the safety and efficacy of the drug.
After submitting a 0570F37359 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 0570F37359 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 0570F37359 suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 0570F37359 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 0570F37359 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 0570F37359 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 0570F37359 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 0570F37359 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 0570F37359 suppliers with NDC on PharmaCompass.
0570F37359 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 0570F37359 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 0570F37359 GMP manufacturer or 0570F37359 GMP API supplier for your needs.
A 0570F37359 CoA (Certificate of Analysis) is a formal document that attests to 0570F37359's compliance with 0570F37359 specifications and serves as a tool for batch-level quality control.
0570F37359 CoA mostly includes findings from lab analyses of a specific batch. For each 0570F37359 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
0570F37359 may be tested according to a variety of international standards, such as European Pharmacopoeia (0570F37359 EP), 0570F37359 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (0570F37359 USP).
Market Place
